Etropal AD (XBUL:ETR) Inventories, Raw Materials & Components: €1.41 Mil (As of Dec. 2025)


XBUL:ETR Etropal AD XBUL:ETR
50 GF Score
Price €2.52
GF Value €8.60
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Etropal AD Inventories, Raw Materials & Components?

Etropal AD XBUL:ETR 50 Inventories, Raw Materials & Components is €1.41 Mil as of Dec. 2025. GuruFocus rates XBUL:ETR with a GF Score™ of 50/100 and a GF Value™ of €8.60 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Etropal AD's inventories, raw materials & components for the quarter that ended in Dec. 2025 was €1.41 Mil.

Etropal AD's quarterly raw materials increased from Dec. 2023 (€0.98 Mil) to Dec. 2024 (€1.33 Mil) and increased from Dec. 2024 (€1.33 Mil) to Dec. 2025 (€1.41 Mil).

Etropal AD's annual raw materials increased from Dec. 2023 (€0.98 Mil) to Dec. 2024 (€1.33 Mil) and increased from Dec. 2024 (€1.33 Mil) to Dec. 2025 (€1.41 Mil).

Etropal AD Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Etropal AD's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Etropal AD Inventories, Raw Materials & Components Chart

Etropal AD Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.53 0.98 1.33 1.41

Etropal AD Semi-Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.53 0.98 1.33 1.41
XBUL:ETR
50GF Score
Etropal AD XBUL:ETR
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Etropal AD Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €1.41 Mil mean?
Etropal AD (XBUL:ETR) has a Inventories, Raw Materials & Components of €1.41 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Etropal AD and its competitors.
Is Etropal AD's Inventories, Raw Materials & Components too high?
Etropal AD's current Inventories, Raw Materials & Components is €1.41 Mil. Overall, Etropal AD has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Etropal AD's Inventories, Raw Materials & Components compare to ISRG and BDX?
Etropal AD's Inventories, Raw Materials & Components of €1.41 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Etropal AD and its competitors. Etropal AD's current Inventories, Raw Materials & Components is €1.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Etropal AD stock overvalued right now?
Based on GuruFocus' analysis, Etropal AD (XBUL:ETR) is currently considered Significantly Undervalued. The stock's GF Value™ is €8.60, compared to a current price of €2.52 — trading 70.7% below its estimated fair value. The current Inventories, Raw Materials & Components is €1.41 Mil. Etropal AD's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Etropal AD (XBUL:ETR), the current Inventories, Raw Materials & Components is €1.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Etropal AD (XBUL:ETR) Overvalued in 2026?

Based on GuruFocus' analysis, Etropal AD stock appears to be undervalued. The current stock price of €2.52 is trading 70.7% below its estimated GF Value™ of €8.60. GuruFocus considers Etropal AD to be Significantly Undervalued.

Key valuation signals for XBUL:ETR:

  • Inventories, Raw Materials & Components: €1.41 Mil
  • GF Value™: €8.60 vs. price of €2.52 (70.7% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the XBUL:ETR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Etropal AD Business Description

Address 191 Rusky Boulevard, Etropole, Sofia, BGR, 2180
Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.
50GF Score

Get the complete analysis for XBUL:ETR

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.52
Price
€8.60
GF Value